Abstract
Prolonged weakness after the use of neuromuscular blocking agents is an increasingly recognized iatrogenic complication of critical care. Vecuronium and pancuronium have been associated with this syndrome, but few cases of atracurium-associated prolonged paresis have heretofore been reported. Many practitioners have thus chosen to use atracurium instead of longer-acting neuromuscular blockers when muscle relaxation is required in the supportive management of critically ill patients. We here report a case of prolonged paresis after the administration of atracurium.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Journal of Respiratory and Critical Care Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
